![Brooks Boyd](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brooks Boyd
Keine laufenden Positionen mehr
Profil
Brooks Boyd worked as Vice President-Product Development at Zogenix, Inc. Boyd holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of California, Davis.
Ehemalige bekannte Positionen von Brooks Boyd
Unternehmen | Position | Ende |
---|---|---|
ZOGENIX, INC. | Corporate Officer/Principal | - |
Ausbildung von Brooks Boyd
University of California, Berkeley | Doctorate Degree |
University of California, Davis | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Zogenix, Inc.
![]() Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |